Objective Surgical site infection (SSI) in colorectal cancer (CRC) has been a serious health
care problem due to the delay of postoperative recovery. Our present study aimed to explore …

Background Surgical site infection (SSI) influenced the result of surgical treatment, which
was known as the second most prevalent hospital-based infection. But, the factors of SSI are …

Aim To identify risk factors for developing surgical site infections (SSIs) based on a
prospective study of patients undergoing colorectal surgery. Methods Between November …

Background Colorectal cancer (CRC) patients undergoing surgery are at a high risk of
developing surgical site infections (SSIs), which contribute to increased morbidity, prolonged …

Background: Surgical site infections (SSIs) represent a noteworthy contributor to both
morbidity and mortality in the context of patients who undergo colorectal surgery. Several …

Extensive gastrointestinal surgery surveillance data in Japan were analyzed to examine the
differences in the risk factors for surgical site infection (SSI) between laparotomy and …

Objective To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime
plus metronidazole (C+ M) for preventing surgical site infections (SSI) in colorectal surgery …

Background Allogeneic red blood cell (RBC) transfusion can induce immunosuppression,
which can then increase the susceptibility to postoperative infection. However, studies in …

In recent years, with the further research on probiotics, probiotics may become an
indispensable part in the prevention and treatment of colorectal cancer (CRC) in the future …

Abstract Background Surgical site infections (SSIs) are among the most common healthcare-
associated infections. Evaluating risk factors for SSIs among patients undergoing …